About Emerald Therapeutics
Emerald Therapeutics is a Healthcare company based in San Francisco (United States) founded in 2010 by D J Kleinbaum and Brian Frezza. Cloud-based remote lab automation software is offered for life sciences. Emerald Therapeutics has raised $39.5 million across 4 funding rounds from investors including SciFi VC, Founders Fund and Schooner Capital. The company has 77 employees. Its chief executive, as recorded, is D J Kleinbaum. Its focus areas include HealthTech, Life Sciences Tech, Research & Development and Laboratory Management. Its competitors include Waters Corporation and Quartzy; 1 of its 2 listed competitors has raised funding.
Company details
Emerald Therapeutics was founded in 2010 in San Francisco, United States, focusing on the life sciences sector. Cloud-based software enables remote access to laboratories via the internet. Automated robotics handle experiment conduction, method design, materials logistics, sample preparation, instrument operation, data acquisition and analysis, troubleshooting, and waste disposal. Operations support research workflows in a distributed manner.
- Headquarters San Francisco, United States
- Employees 77
- Founders D J Kleinbaum, Brian Frezza
- SectorsHealthcare
- Website emeraldcloudlab.com
- Social LinkedIn
- Legal Name Emerald Therapeutics
- Total Equity Funding$39.5M (USD)
in 4 rounds
- Latest Funding Round$20M (USD), Series C
Jun 2015
- InvestorsSciFi VC
& 3 more
- Employee Count77
Funding Insights of Emerald Therapeutics
Emerald Therapeutics has successfully raised a total of $39.5M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $20 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $39.5M
- Total Rounds 4
- Last Round Series C — $20M
- First Round $5M
(Dec 2010)
- Investors Count 4
All 4 funding rounds of Emerald Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2015 | $20M | Series C | – | – | – |
| Feb 2014 | $13.5M | Series B | – | Founders Fund, Max Levchin | |
| Mar 2012 | $1M | Series A | – | – | – |
| Dec 2010 | $5M | Series A | – | – | – |
4 investors in total: 3 institutional and 1 angel.
Investors in Emerald Therapeutics
Emerald Therapeutics has secured backing from 4 investors, including venture fund and angel investors. Prominent investors backing the company include SciFi VC, Founders Fund and Schooner Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are directed toward early-stage consumer-tech startups. | scifi.vc | San Francisco, United States | ||
Venture capital investments in technology and defense sectors. | foundersfund.com | |||
Private equity investments are directed across multiple sectors. | schoonercapital.com | Boston, United States | ||
ML Max Levchin | Co-founder of PayPal, Affirm CEO, prominent tech investor | unknown_551b0c837e0c4f6c9 |
Investor details for Emerald Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Emerald Therapeutics
2 people are tracked at Emerald Therapeutics (2 in leadership); the tracked headcount is 77.
| Name | Role | Group |
|---|---|---|
D J Kleinbaum | Co-Founder & Co-CEO | Leadership |
Brian Frezza | Co-Founder & Co-CEO | Leadership |
Complete people profiles for Emerald Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Emerald Therapeutics
3 dated milestones of Emerald Therapeutics across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Emerald Therapeutics is founded.
- Funding First funding round of $5.0M.
- Funding Latest funding round, Series C, of $20.0M.
Competitors of Emerald Therapeutics
Emerald Therapeutics has 2 listed competitors in our database, 1 of them funded. They include Waters Corporation and Quartzy.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| waters.com | 1958 | Milford, United States | 9,341 | Provider of laboratory management system for researchers and clinicians | ||
| quartzy.com | 2009 | Palo Alto, United States | $33.87M | 97 | Lab management platform for life sciences is offered by Quartzy. |
Detailed competitors of Emerald Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Emerald Therapeutics
The website of Emerald Therapeutics (emeraldcloudlab.com) receives about 7.6K visits a month.
- Monthly visits7.6K
▼ 28.8% vs previous month
Websites whose visitors overlap most with Emerald Therapeutics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
rsb.org.uk | rsb.org.uk | 100% | #381,317 | – | |
| biospace.com | 100% | 720.1K | #88,394 | View details | |
| doodle.com | 100% | 6.7M | #11,058 | View details | |
| scienceexchange.com | 80% | 2.9K | #4,037,937 | View details | |
digitallearn.org | digitallearn.org | 72% | #1,425,842 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for Emerald Therapeutics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Emerald Therapeutics (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Emerald Therapeutics
Complete news archive for Emerald Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Emerald Therapeutics
Emerald Therapeutics was founded in 2010.
Emerald Therapeutics is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
D J Kleinbaum is the CEO of Emerald Therapeutics, as recorded in our data. They have also founded this company.
Emerald Therapeutics is a funded company, having raised a total of $39.5M across 4 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Dec 2010.
Emerald Therapeutics has 77 employees.
Emerald Therapeutics was founded in 2010 in San Francisco, United States, focusing on the life sciences sector. Cloud-based software enables remote access to laboratories via the internet. Automated robotics handle experiment conduction, method design, materials logistics, sample preparation, instrument operation, data acquisition and analysis, troubleshooting, and waste disposal. Operations support research workflows in a distributed manner.
Emerald Therapeutics's top competitors include Waters Corporation and Quartzy.
Emerald Therapeutics has 4 investors. Key investors include SciFi VC, Founders Fund, Schooner Capital, and Max Levchin.
Emerald Therapeutics operates through Emerald Therapeutics.